Cargando…
Current Devices in TMVI and Their Limitations: Focus on Tendyne
Mitral valve regurgitation (MR) has a high incidence in the western world, and mortality is high for untreated severe MR. Catheter based repair was introduced with MitraClip in 2003, and some additional devices later came into the market. To expand the transcatheter treatment options for mitral valv...
Autor principal: | Dahle, Gry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793646/ https://www.ncbi.nlm.nih.gov/pubmed/33425997 http://dx.doi.org/10.3389/fcvm.2020.592909 |
Ejemplares similares
-
Editorial: Minimally invasive cardiac surgery: state of the art and current challenges
por: Holubec, Tomas, et al.
Publicado: (2023) -
Multicenter Clinical Management Practice to Optimize Outcomes Following Tendyne Transcatheter Mitral Valve Replacement
por: Duncan, Alison, et al.
Publicado: (2022) -
Correction: Characteristics and outcomes of patients undergoing transcatheter mitral valve replacement with the Tendyne system
por: Wilde, Nihal, et al.
Publicado: (2023) -
Cardiac Surgery in Nonagenarians Following the TAVI/TMVI Era: A Multicenter 23-Year Comparative Analysis †
por: Nasso, Giuseppe, et al.
Publicado: (2023) -
Current Devices in Mitral Valve Replacement and Their Potential Complications
por: Gheorghe, Livia, et al.
Publicado: (2020)